Ellen Rietmann Ahl is a growth investor specializing in Life Science, HealthTech, FoodTech, and AgTech at Swisscanto by ZKB Asset Management. They have served as a board observer for MedTrace Pharma A/S and OncoDNA since 2024, and were previously the managing director and founding member at VetWelding AG from 2017 to 2021. Ellen's diverse experience includes roles in marketing, business development, and logistics with companies such as Ericsson, AstraZeneca, and Volvo Car Group. They hold a Master's degree in Management and Economics of Innovation from Chalmers University of Technology and have furthered their education in Industrial Engineering and Management at both Chalmers and the Technical University of Munich.
This person is not in the org chart
This person is not in any teams
This person is not in any offices